Market Overview

Stroke Diagnostics & Therapeutics - $49.7 Billion Worldwide Market Outlook to 2026 featuring Siemens, GE, Medtronic, Bayer, Abbott, Merck, BMS, and More -


The "Stroke
Diagnostics and Therapeutics - Global Market Outlook (2017-2026)"

report has been added to's

According to the report, the market accounted for $23,849.39 Million in
2017 and is expected to reach $49,698.68 Million by 2026 growing at a
CAGR of 8.5% during the forecast period.

Factors such as technological advancement, growing aging population, and
people suffering from diabetes are favoring the market. On the other
hand, increasing health expenditure, hypertension and also increasing
tobacco users are also fuelling the market. However factors such as
unfavorable reimbursement scenario and high cost of treatments are
hampering the market growth.

By Geography, Asia is expected to witness high growth rate and is
expected to remain on top among other regions in the forecast period due
to growing aging population, evolving R&D activities for drug discovery
and development, increasing government support in the form of funding
and developing healthcare infrastructure in the region. In addition,
growing demographics and economies in the developing countries such as
India, China, and Japan are expected to lead the growth in the stroke
diagnostics and therapeutics market in Asia.

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porter's Five Force Analysis

5 Global Stroke Diagnostics and Therapeutics Market, By Type

6 Global Stroke Diagnostics and Therapeutics Market, By Application

7 Global Stroke Diagnostics and Therapeutics Market, By Geography

8 Key Developments

9 Company Profiling

  • Siemens AG
  • GE Healthcare
  • Medtronic PLC
  • Bayer AG
  • Abbott Laboratories
  • Cordis Corporation
  • Boston Scientific Corporation
  • Genentech Inc.
  • Koninklijke Philips N.V.
  • Stryker Corporation
  • Merck & Co. Inc.
  • B. Braun Melsungen AG
  • Teleflex Inc.
  • Cardinal Health
  • Merck Sharp & Dohme Corp.
  • GlaxoSmithKline PLC
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Johnson & Johnson
  • Daiichi Sankyo

For more information about this report visit

View Comments and Join the Discussion!